[Hyderabad, April 30th, 2025] – The global clinical trials market is experiencing transformative growth, projected to surge from USD 52.8 billion in 2023 to USD 91.1 billion by 2031, expanding at a 7.1% CAGR  ClearView Market Insights, 2024.This expansion is driven by advancements in decentralized trials, precision medicine, and AI-driven patient recruitment across three pivotal segments:

Request Sample @ https://clearviewmarketinsights.com/report-details/global-clinical-trials-market/

Decentralized Clinical Trials (DCT) Surge:

·       Pfizer’s COVID-19 vaccine trials accelerated using a hybrid DCT model, leading to a 30% reduction in patient dropout rates.

·       Medable’s DCT platform facilitated a 40% faster enrollment across oncology and rare disease studies.

·       In 2024, FDA guidance formally endorses remote monitoring, driving industry-wide DCT adoption.

Precision Medicine Focus:

·       Adaptive Trial Designs: Moderna’s personalized mRNA cancer vaccine trials adopt basket trial models, cutting Phase II timelines by 25%.

·       Genomic Screening: Foundation Medicine’s platform integrates genomic profiling to optimize patient stratification in clinical trials.

·       Companion Diagnostics: Roche expands its FDA-approved companion diagnostics portfolio to cover emerging immunotherapy candidates.

AI-Driven Patient Recruitment:

·       Deep 6 AI’s platform identifies eligible patients 20x faster, boosting enrollment speed by 32% for rare disease trials.

·       Trialbee’s AI recruitment tools increase patient diversity, achieving 60% minority representation in U.S.-based trials.

·       IBM’s AI algorithms predict site performance, reducing trial site failures by 18%.

2024 Breakthroughs

Commercialization Milestones

Investment & R&D Trends:

·       Startup Funding: USD 3.8 billion raised in 2023 for clinical trial tech platforms (e.g., Science 37’s USD 250M Series D).

·       Corporate R&D: Up 22% YoY, with:

·       IQVIA: USD 400M invested in next-gen clinical trial software.

·       Parexel: USD 250M dedicated to expanding DCT capabilities globally.

Executive Insights

·       "Decentralization is no longer optional; it is reshaping patient-centricity in every phase of clinical research." — Dr. Michelle Longmire, CEO, Medable

·       "AI is helping us build smarter trials—accelerating time-to-market for therapies that patients desperately need." — Dr. Arthur Tzianabos, CEO, Unlearn.AI

Regional Analysis

North America (XX% Market Share):

·       NIH’s new funding of USD 2 billion prioritizes decentralized and patient-centric trial initiatives.

·       FDA’s Project Optimus reshapes oncology trial design standards, encouraging adaptive methodologies.

Europe (XX% Share):

·       EMA’s Remote Monitoring Framework boosts DCT adoption across EU member states.

·       Horizon Europe’s €1.5 billion investment supports personalized medicine trials and AI-driven trial management.

Asia-Pacific (XX % Share):

·       China’s NMPA fast-tracks approval for DCT models in oncology and rare disease trials.

·       India’s CDSCO launches a regulatory sandbox to streamline decentralized trial approvals.

Future Roadmap:

·       2025: AI-driven synthetic control arms adopted in 30% of new oncology trials.

·       2027: Blockchain-based eConsent platforms become industry standard.

·       2030: Personalized multi-omic clinical trials become mainstream, integrating genomics, proteomics, and metabolomics.

Company Spotlight:

1.     Medable

-       Market Position: Leader in DCT solutions with over 150 deployments globally.

-       2024 Innovation: Launch of "Medable 360," a unified decentralized trial ecosystem.

-       Growth Strategy: Forge strategic partnerships with leading CROs to enhance access to underserved populations.

2.     Unlearn.AI:

-       Breakthrough: First FDA submission using a virtual control arm for Alzheimer's trials.

-       Partnerships: Collaborating with top 10 pharma companies on AI-based trial design.

For more insights, visit https://clearviewmarketinsights.com/report-store

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

Media contact:

Bhavani K

Marketing and Sales Head

ClearView Market Insights

Mail: sales@clearviewmarketinsights.com

Phone: +1 917-993-736